The DRUGMATRIX assay involves the inhibition of the Phosphodiesterase PDE5 enzyme, specifically targeting a single protein. The substrate used is [3H]cGMP + cGMP. The assay utilizes Platelet cells and is conducted in vitro on the Homo sapiens organism. The assay type is described as Binding. Does the molecule show efficacy in this assay?